FDA Import Refusal 799-1724473-4/11/1 — Merck, Sharp & Dohme
The FDA refused shipment 799-1724473-4/11/1 from Merck, Sharp & Dohme (United Kingdom) on Jun 13, 2024. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 13, 2024
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 75